Nephris Srl
Latest round
- Seed
Last raised
- Apr 2022
Total raised
- $3.2M
Investors
- 1
About Nephris Srl
Founded in 2021 by Paolo Fiorina and Francesca D’Addio, and based in Italy, Nephris Srl operates as a pre-clinical-stage biotech company focused on new targets of kidney disease progression. The company offers research and development of therapies in diabetic nephropathy that, can improve kidney function. The company deals with patients suffering from type 1 and type 2 diabetes and offers new treatments that could prevent, treat, and reverse diabetic kidney disease. The platform also provides research and treatment for chronic kidney diseases.
Who invested in Nephris Srl
1 investor across 1 round
See all investors in Nephris Srl
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 20, 2022
Amount
$3.2M
Investors
Questions about Nephris Srl
Who invested in Nephris Srl?
Nephris Srl has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nephris Srl raised?
Nephris Srl has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nephris Srl last raise money?
Nephris Srl's most recent round on record is a Seed, in Apr 2022.
What does Nephris Srl do?
Founded in 2021 by Paolo Fiorina and Francesca D’Addio, and based in Italy, Nephris Srl operates as a pre-clinical-stage biotech company focused on new targets of kidney disease progression.
Where is Nephris Srl headquartered?
Nephris Srl is headquartered in Milan, Italy.
Which VCs invest in companies like Nephris Srl?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Nephris Srl's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Nephris Srl? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.